March 2, 2018 / 1:23 PM / in 9 months

BRIEF-Vaxart Says Data Shows Orally Administered Norovirus Tablet Vaccine Was Well-Tolerated

March 2 (Reuters) - Vaxart Inc:

* VAXART - DATA SHOWS ORALLY ADMINISTERED NOROVIRUS TABLET VACCINE WAS WELL-TOLERATED, GENERATED ROBUST SYSTEMIC AND LOCAL INTESTINAL IMMUNE RESPONSES

* VAXART INC - DID NOT SEE ANY EVIDENCE OF ANTI-VECTOR IMMUNITY WITH NOROVIRUS ORAL TABLET VACCINE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below